These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 12788799

  • 1. Cardiovascular function in acromegaly.
    Clayton RN.
    Endocr Rev; 2003 Jun; 24(3):272-7. PubMed ID: 12788799
    [Abstract] [Full Text] [Related]

  • 2. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A.
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [Abstract] [Full Text] [Related]

  • 3. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.
    Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Florimonte L, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 1999 Jan; 84(1):17-23. PubMed ID: 9920056
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cardiac abnormalities in acromegaly. Pathophysiology and implications for management.
    Vitale G, Pivonello R, Lombardi G, Colao A.
    Treat Endocrinol; 2004 Jan; 3(5):309-18. PubMed ID: 15330678
    [Abstract] [Full Text] [Related]

  • 9. Cardiac effect of thyrotoxicosis in acromegaly.
    Marzullo P, Cuocolo A, Ferone D, Pivonello R, Salvatore M, Lombardi G, Colao A.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular involvement in patients affected by acromegaly: an appraisal.
    Mosca S, Paolillo S, Colao A, Bossone E, Cittadini A, Iudice FL, Parente A, Conte S, Rengo G, Leosco D, Trimarco B, Filardi PP.
    Int J Cardiol; 2013 Sep 01; 167(5):1712-8. PubMed ID: 23219077
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly.
    Fazio S, Cittadini A, Cuocolo A, Merola B, Sabatini D, Colao A, Biondi B, Lombardi G, Saccà L.
    J Clin Endocrinol Metab; 1994 Aug 01; 79(2):441-6. PubMed ID: 8045960
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reduced nitric oxide levels in acromegaly: cardiovascular implications.
    Ronconi V, Giacchetti G, Mariniello B, Camilletti A, Mantero F, Boscaro M, Vignini A, Mazzanti L.
    Blood Press; 2005 Aug 01; 14(4):227-32. PubMed ID: 16126556
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle.
    Rodrigues EA, Caruana MP, Lahiri A, Nabarro JD, Jacobs HS, Raftery EB.
    Br Heart J; 1989 Sep 01; 62(3):185-94. PubMed ID: 2528980
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.